Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | APEX1 | P27695 | 1/20 | 0.43 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phthalic Acid SCHEMBL27719965 | 0.89 | ALDH1A1 (0.56) | ALDH1A1ALOX15MAPK1TSHRHTT | |
| Phthalic Acid SCHEMBL81888 | 0.86 | TSHR (0.64) | ALDH1A1ALOX15MAPK1TSHRHTT | |
| Phthalic Acid SCHEMBL31495206 | 0.86 | TSHR (0.64) | ALDH1A1ALOX15MAPK1TSHRHTT | |
| Phthalic Acid SCHEMBL27744826 | 0.82 | KDM4E (0.49) | ALDH1A1ALOX15TSHRHTTKMT2A | |
| Phthalic Acid SCHEMBL7203558 | 0.82 | ALDH1A1 (0.70) | ALDH1A1ALOX15HTTKMT2AHPGD | |
| Phthalic Acid SCHEMBL27790612 | 0.82 | ALDH1A1 (0.70) | ALDH1A1ALOX15TSHRHTTKMT2A | |
| Phthalic Acid SCHEMBL10360600 | 0.82 | ALDH1A1 (0.70) | ALDH1A1ALOX15HTTKMT2AHPGD | |
| Phthalic Acid SCHEMBL27697914 | 0.81 | ALDH1A1 (0.56) | ALDH1A1ALOX15MAPK1TSHRHTT | |
| Phthalic Acid SCHEMBL9804564 | 0.81 | ALDH1A1 (0.59) | ALDH1A1ALOX15MAPK1TSHRHTT | |
| SCHEMBL28117434 | 0.81 | TSHR (0.69) | ALDH1A1ALOX15MAPK1TSHRKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180264019-A1 | COMPOSITION, DEVICE AND METHOD FOR DELAYED AND SUSTAINED RELEASE OF BRAIN ENERGY MOLECULES | ABLE CEREBRAL, LLC | 2018-09-20 | — | — | US | claimed |
| US-10016370-B2 | Composition, device and method for delayed and sustained release of brain energy molecules | ABLE CEREBRAL, LLC (US) | 2018-07-10 | — | — | US | claimed |
| CN-101453990-B | Bupropion controllable release formulations and manufacturing process thereof | BIOKEY INC | 2015-05-13 | — | — | CN | claimed |
| CN-103945832-A | A composition, device and method for delayed and sustained release of brain energy molecules | JACKS HEALTH TECHNOLOGIES LLC | 2014-07-23 | — | — | CN | claimed |
| US-20140180224-A1 | COMPOSITION, DEVICE AND METHOD FOR DELAYED AND SUSTAINED RELEASE OF BRAIN ENERGY MOLECULES | ABLE CEREBRAL, LLC | 2014-06-26 | — | — | US | claimed |
| EP-2731593-A2 | A COMPOSITION, DEVICE AND METHOD FOR DELAYED AND SUSTAINED RELEASE OF BRAIN ENERGY MOLECULES | Able Cerebral, LLC (US) | 2014-05-21 | — | — | EP | claimed |
| US-8586085-B2 | Methods and formulations for making pharmaceutical compositions containing bupropion | BIOKEY, INC. (US) | 2013-11-19 | — | — | US | claimed |
| WO-2013010137-A2 | A COMPOSITION, DEVICE AND METHOD FOR DELAYED AND SUSTAINED RELEASE OF BRAIN ENERGY MOLECULES | JACKS HEALTH TECHNOLOGIES LLC (US) | 2013-01-17 | — | — | WO | claimed |
| CN-102475719-A | A pharmaceutical composition for treating upper respiratory infection of children, and its preparation method | SHINEWAY PHARMACEUTICAL CO LTD | 2012-05-30 | — | — | CN | claimed |
| US-20090162431-A1 | Sustained release formulations containing acetaminophen and tramadol | ZHANG SHUYI | 2009-06-25 | — | — | US | claimed |
| WO-2006053089-A2 | METHODS AND FORMULATIONS FOR MAKING PHARMACEUTICAL COMPOSITIONS CONTAINING BUPROPION | BIOKEY, INC. (US) | 2006-05-18 | — | — | WO | claimed |
| US-20060099260-A1 | Methods and formulations for making pharmaceutical compositions containing bupropion | BIOKEY, INC. | 2006-05-11 | — | — | US | claimed |
| US-20060099262-A1 | Methods and formulations for making controlled release oral dosage form | BIOKEY, INC. | 2006-05-11 | — | — | US | claimed |
| US-20060099261-A1 | Methods and formulations for making controlled release oral dosage form | BIOKEY, INC. | 2006-05-11 | — | — | US | claimed |
| EP-1555022-A1 | SUSTAINED RELEASE COMPOUND OF ACETAMIDOPHENOL AND TRAMADOL | Zhang, Shugi (CN) | 2005-07-20 | — | — | EP | claimed |
| US-20040131671-A1 | Sustained release formulations containing acetaminophen and tramadol | ZHANG SHUYI (US) | 2004-07-08 | — | — | US | claimed |
| CN-1403078-A | Slow-releasing prepn containing p-acetamidophenol and opium | SHANGHAI YAHU PHARMACEUTICAL C (CN) | 2003-03-19 | — | — | CN | claimed |
| EP-1035840-A1 | SUSTAINED RELEASE FORMULATION CONTAINING THREE DIFFERENT TYPES OF POLYMERS AND TABLET FORMED THEREFROM | Duramed Pharmaceuticals Inc. (US) | 2000-09-20 | — | — | EP | claimed |
| US-6083532-A | TABLETS FOR SUSTAINED RELEASE OF DRUGS AND GELLING POLYMER | DURAMED PHARMACEUTICALS, INC. (US) | 2000-07-04 | — | — | US | claimed |
| WO-1999029305-A1 | SUSTAINED RELEASE FORMULATION CONTAINING THREE DIFFERENT TYPES OF POLYMERS AND TABLET FORMED THEREFROM | DURAMED PHARMACEUTICALS, INC. (US) | 1999-06-17 | — | — | WO | claimed |